Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 10, 2014, Pages 1370-1379

  Hau, C S ^a,b   Kanda, N ^a   Tada, Y ^b   Shibata, S ^b   Sato, S ^b   Watanabe, S ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMIQUIMOD; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; INTERLEUKIN 23P19; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; PROLACTIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; AMINOQUINOLINE DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DERMATITIS; DISEASE EXACERBATION; DISEASE SEVERITY; ERYTHEMA; FEMALE; MOUSE; NONHUMAN; PSORIASIS; TH1 CELL; TH17 CELL; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; REAL TIME POLYMERASE CHAIN REACTION;

AMINOQUINOLINES; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; PROLACTIN; PSORIASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; TH1 CELLS; TH17 CELLS;

EID: 84908105293     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12295     Document Type: Article

References (54)

1. Lew W, Bowcock AM, Krueger JG,. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "type 1" inflammatory gene expression. Trends Immunol 2004; 25: 295-305.
2. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al,. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 cells. J Invest Dermatol 2008; 128: 1207-1211.
3. Dilmé-Carreras E, Martin-Ezquerra G, Sanchez-Regaña M, Umbert-Millet P,. Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol 2011; 36: 29-32.
4. Foitzik K, Langan EA, Paus R,. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 2009; 129: 1071-1087.
5. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW,. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996; 17: 639-669.
6. Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R,. Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab 2010; 21: 569-577.
7. Paus R,. Does prolactin play a role in skin biology and pathology? Med Hypotheses 1991; 36: 33-42.
8. Girolomoni G, Phillips JT, Bergstresser PR,. Prolactin stimulates proliferation of cultured human keratinocytes. J Invest Dermatol 1993; 101: 275-279.
9. Sodhi A, Tripathi A,. Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: involvement of p-38 MAP kinase, STAT3 and NF-κB. Cytokine 2008; 41: 162-173.
10. Matera L, Mori M,. Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. Ann N Y Acad Sci 2000; 917: 505-513.
11. Cesario TC, Yousefi S, Carandang G, Sadati N, Le J, Vaziri N,. Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells. Proc Soc Exp Biol Med 1994; 205: 89-95.
12. Giasuddin AS, El-Sherif AI, El-Ojali SI,. Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology 1998; 197: 119-122.
13. El-Khateeb EA, Zuel-Fakkar NM, Eid SM, Abdul-Wahab SE,. Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol 2011; 50: 693-696.
14. Guilhou JJ, Guilhou E,. Bromocriptine treatment of psoriasis. Arch Dermatol Res 1982; 273: 159-160.
15. Valentino A, Fimiani M, Bilenchi R, et al,. Therapy with bromocriptine and behavior of various hormones in psoriasis patients. Boll Soc Ital Biol Sper 1984; 60: 1841-1844.
16. Sanchez Regaña M, Umbert-Millet P,. Psoriasis in association with prolactinoma. Br J Dermatol 2000; 143: 864-867.
17. Kanda N, Watanabe S,. Prolactin enhances interferon-γ-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 2007; 148: 2317-2325.
18. Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S,. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 2009; 39: 996-1006.
19. Greaves MW, Weinstein GD,. Treatment of psoriasis. N Engl J Med 1995; 332: 581-588.
20. Griffiths CE, Barker JN,. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-271.
21. van der Fits L, Mourits S, Voerman JS, et al,. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL23/IL-17 axis. J Immunol 2009; 182: 5836-5845.
22. Gilliet M, Conrad C, Geiges M, et al,. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004; 140: 1490-1495.
23. Cai Y, Shen X, Ding C, et al,. Pivotal role of dermal IL-17-producing gamma delta T cells in skin inflammation. Immunity 2011; 35: 596-610.
24. Olazabal IM, Muñoz JA, Rodriguez-Navas C, Alvarez L, Delgado-Baeza E, García-Ruiz JP,. Prolactin's role in the early stages of liver regeneration in rats. J Cell Physiol 2009; 219: 626-633.
25. Williams I, Ellich B, Kupper TS,. Cytokines. In, Wolff K, Katz SI, Goldsmith LA, Gilchrest B, Paller A, Lefell D, eds. Fitzpatrick's Dermatology in General Medicine, 7th edn. McGraw-Hill: New York, 2008: 115-126.
26. Gudjonsson JE, Elder JT,. Psoriasis. In, Wolff K, Katz SI, Goldsmith LA, Gilchrest B, Paller A, Lefell D, eds. Fitzpatrick's Dermatology in General Medicine. 7th edn. McGraw-Hill: New York, 2008; 169-193.
27. Lowes MA, Bowcock AM, Krueger JG,. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
28. Di Cesare A, Di Meglio P, Nestle FO,. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009; 129: 1339-1350.
29. Harper EG, Guo C, Rizzo H, et al,. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 2009; 129: 2175-2183.
30. Sirsjö A, Karlsson M, Gidlöf A, et al,. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996; 134: 643-648.
31. Takeda K, Akira S,. STAT family of transcription factors in cytokine-mediated biological response. Cytokine Growth Factor Rev 2000; 11: 199.
32. DaSilva L, Rui H, Erwin RA, etal. Prolactin recruits STAT1, STAT3, and STAT5 independent of conserved receptor tyrosines Tyr402, Tyr479, Tyr515, and Tyr580. Mol Cell Endocrinol 1996; 117: 131.
33. Maddur MS, Miossec P, Kaveri SV, Bayry J,. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012; 181: 8-18.
34. Leonard WJ, O'Shea JJ,. Jaks and STATs: biological implications. Annu Rev Immunol 1998; 16: 293-322.
35. Hirano T, Ishihara K, Hibi M,. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19: 2548-2556.
36. Levy DE, Darnell JE Jr,. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3: 651-662.
37. McKenzie RC, Sabin E,. Aberrant signaling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 2003; 12: 337-345.
38. Sano S, Chan KS, Carbajal S, et al,. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005; 11: 43-49.
39. + -ATPase 2 expression by prolactin and glucocorticoids is involved in the adaptation of insulin secretory response during the peripartum period. J Endocrinol 2007; 195: 17-27.
40. Bordin S, Amaral ME, Anhê GF, et al,. Prolactin-modulated gene expression profiles in pancreatic islets from adult female rats. Mol Cell Endocrinol 2004; 220: 41-50.
41. Lee E, Trepicchio WL, Oestreicher JL, et al,. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004; 199: 125-130.
42. + innate lymphocytes and γδ t cells initiate psoriasiform plaque formation in mice. J Clin Invest 2012; 122: 2252-2256.
43. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A,. Prolactin and autoimmunity. Pituitary 2005; 8: 25-30.
44. Griffin GK, Newton G, Tarrio ML, et al,. IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 2012; 188: 6287-6299.
45. Orlichenko LS, Behari J, Yeh TH, et al,. Transcriptional regulation of CXC-ELR chemokines KC and MIP-2 in mouse pancreatic acini. Am J Physiol Gastrointest Liver Physiol 2010; 299: G867-G876.
46. Kloepper JE, Kawai K, Bertolini M, et al,. Loss of γδ T cells results in hair cycling defects. J Invest Dermatol 2013; 133: 1666-1669.
47. Foitzik K, Krause K, Conrad F, et al,. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 2006; 168: 748-756.
48. Lennartsson AK, Jonsdottir IH,. Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 2011; 36: 1530-1539.
49. Arnetz BB, Fjellner B, Eneroth P, Kallner A,. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985; 47: 528-541.
50. Al'Abadie MS, Kent GG, Gawkrodger DJ,. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203.
51. Fortune DG, Richards HL, Kirby B, et al,. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752-756.
52. Dunna SF, Finlay AY,. Psoriasis: improvement during and worsening after pregnancy. Br J Dermatol 1989; 120: 584.
53. Welte T, Reagan K, Fang H, et al,. Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J Gen Virol 2009; 90: 2660-2668.
54. Langan EA, Griffiths CE, Paus R,. Exploring the role of prolactin in psoriasis. Arch Dermatol Res 2012; 304: 115-118.